Streptomyces griseus subsp. griseus (Krainsky) Waksman and Henrici
商品貨號(hào)
B169024
Strain Designations
7 [IFO 3746]
Application
Produces chromomycin A3
Produces cytochrome P450
Isolation
Soil, Toyonaka, Japan
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Disclosure
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Preceptrol®
no
Type Strain
no
Medium
ATCC® Medium 1877: ISP Medium 1
ATCC® Medium 196: Yeast malt extract agar
Montanari A, Rosazza JP. Biogenesis of chromomycin A3 by Streptomyces griseus. J. Antibiot. 43: 883-889, 1990. PubMed: 2117602
Miyake A, et al. Substances belonging to chromomycin A group and their production. US Patent 3,313,691 dated Apr 11 1967
Kunz DA, Sariaslani SF. Process for inducing cytochrome P-450 enzymes in Streptomyces bacteria and determining the mutagenicity of chemicals. US Patent 5,674,714 dated Oct 7 1997
Cross References
Nucleotide (GenBank) :
X63601
S.griseus soyC and soyB genes.
